These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38600288)
1. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants. Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288 [TBL] [Abstract][Full Text] [Related]
2. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers. Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262 [TBL] [Abstract][Full Text] [Related]
3. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen. Buttini F; Glieca S; Sonvico F; Lewis DA Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756 [TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential. Aurivillius M; Bednarczyk A; Kokot M; Madriaga J; Mei J; Collison K; Surujbally R; Archbell J; Joshi V; Gillen M Pulm Pharmacol Ther; 2023 Dec; 83():102245. PubMed ID: 37607661 [TBL] [Abstract][Full Text] [Related]
5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Williams RO; Repka M; Liu J Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524 [TBL] [Abstract][Full Text] [Related]
6. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers. D'Sa D; Chan HK Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200 [TBL] [Abstract][Full Text] [Related]
7. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers. Liao YH; Brown MB; Jones SA; Nazir T; Martin GP Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753 [TBL] [Abstract][Full Text] [Related]
8. Moisture uptake and its influence on pressurized metered-dose inhalers. Williams RO; Hu C Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745 [TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs. Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687 [TBL] [Abstract][Full Text] [Related]
10. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations. D'Sa DJ; Lechuga-Ballesteros D; Chan HK Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449 [TBL] [Abstract][Full Text] [Related]
11. The Climate is Changing for Metered-Dose Inhalers and Action is Needed. Pritchard JN Drug Des Devel Ther; 2020; 14():3043-3055. PubMed ID: 32801643 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Cripps A; Riebe M; Schulze M; Woodhouse R Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679 [TBL] [Abstract][Full Text] [Related]
15. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs. Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
17. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers. Ju D; Shrimpton J; Hearn A Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471 [TBL] [Abstract][Full Text] [Related]
18. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes. Wu L; Al-Haydari M; da Rocha SR Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015 [TBL] [Abstract][Full Text] [Related]
19. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers. Sheth P; Stein SW; Myrdal PB Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912 [TBL] [Abstract][Full Text] [Related]
20. Canister valve and actuator deposition in metered dose inhalers formulated with low-GWP propellants. Duke DJ; Rao L; Kastengren A; Myatt B; Cocks P; Stein S; Marasini N; Ong HX; Young P Int J Pharm; 2023 Dec; 648():123569. PubMed ID: 37925043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]